Back
Sarepta Therapeutics Vs. Affirm Holdings Industry Stock Comparison
Sell
43
SRPT
Sarepta Therapeutics
Last Price:
160.73
Seasonality Move:
13.83%
Buy
53
AFRM
Affirm Holdings
Last Price:
29.86
Seasonality Move:
46.19%
Sell
43
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $123.56. The Score for SRPT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Affirm Holdings (AFRM)
is a Buy
Is Affirm Holdings a Buy, Sell or Hold?
- The current Affirm Holdings [AFRM] share price is $30.14. The Score for AFRM is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- AFRM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $123.56
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
AFRM Stock Price Chart
What is Affirm Holdings's stock price today?
-
The Affirm Holdings share price today is $30.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AFRM is experiencing slight buying pressure.
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.66 | Sell |
| Relative Strength Index (14 RSI): | 50.38 | Buy |
| Chaikin Money Flow: | 1128064 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (118.42 - 129.08) | Sell |
| Bollinger Bands (100): | (120.21 - 131.53) | Sell |
AFRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 45.32 | Sell |
| Chaikin Money Flow: | 598132 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.35 - 32.81) | Sell |
| Bollinger Bands (100): | (30.83 - 39.17) | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 121.23 | Buy |
| 20-day SMA: | 121.86 | Buy |
| 50-day SMA: | 125 | Sell |
| 200-day SMA: | 114.69 | Buy |
| 8-day EMA: | 121.07 | Buy |
| 20-day EMA: | 122.55 | Buy |
| 50-day EMA: | 124.12 | Sell |
| 200-day EMA: | 119.07 | Buy |
AFRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.98 | Sell |
| 20-day SMA: | 30.71 | Sell |
| 50-day SMA: | 31.9 | Sell |
| 200-day SMA: | 32.56 | Sell |
| 8-day EMA: | 31.21 | Sell |
| 20-day EMA: | 31.35 | Sell |
| 50-day EMA: | 32.31 | Sell |
| 200-day EMA: | 31.48 | Sell |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.04 per share, an increase next quarter of $1.33 per share, an increase this year of $5.96 per share, and an increase next year of $5.92 per share.
Affirm Holdings Earnings Growth & AFRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.10 per share, and an increase next year of $0.04 per share.
Sarepta Therapeutics Technical Analysis
| Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Affirm Holdings Technical Analysis
| Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||